Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-8 of 8
1-8 of 8
Filter
Chris Cooper
Founder and CEO at Lucent Botanicals
anti-inflammatory, aromatherapy, aromaticity, behavior, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, chromium, dietary supplement, dose (biochemistry), drink, entourage effect, epilepsy, essential oil, food, food and drug administration, good manufacturing practice, hemp, herbal distillate, herbal medicine, hindsight bias, juice, lemon, ligand (biochemistry), limonene, mango, medication, medicine, mind, pharmaceutical industry, route of administration, secondary metabolite, spectrum, synergy, terpene, terpenoid, tetrahydrocannabinol, time, traditional chinese medicine, water, water activity
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Annie Epley
Director of Operations at From Soil to Soul, LLC
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Carl Sheeler
Co-Founder at Two Bears Farm
behavior, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), charlotte's web (cannabis), commodity, dietary supplement, dose (biochemistry), electronic cigarette, entourage effect, farmer, fda warning letter, flavonoid, food and drug administration, genetically modified food, hemp, herbicide, insomnia, lemon, medical cannabis, medication, nsf international, organic certification, pain, pharmaceutical industry, polypharmacy, price, reason, scientific method, solution, terpene, tetrahydrocannabinol, tobacco, toxicity, understanding, warren buffett, water
Hyla Cass
Editorial Advisor and Contributing Writer at Total Health Maga
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), charlotte's web (cannabis), dietary supplement, dose (biochemistry), entourage effect, fda warning letter, flavonoid, food and drug administration, hemp, lemon, medical cannabis, medication, pharmaceutical industry, polypharmacy, reason, scientific method, terpene, tetrahydrocannabinol, toxicity, understanding, water
Justin Benton
CEO at 101 CBD
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), charlotte's web (cannabis), dietary supplement, dose (biochemistry), entourage effect, fda warning letter, flavonoid, food and drug administration, hemp, lemon, medical cannabis, medication, pharmaceutical industry, polypharmacy, reason, scientific method, terpene, tetrahydrocannabinol, toxicity, understanding, water
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
1
1-8 of 8